Site icon OncologyTube

Metastatic Renal Cell Cancer: Who Deserves Monotherapy?

Primo N Lara, Jr., MD Director, University of California Davis Comprehensive Cancer Center Professor of Medicine and Executive Associate Dean for Cancer Programs UC Davis School of Medicine, Sacramento, CA discusses Metastatic Renal Cell Cancer: Who Deserves Monotherapy? From the Seventeenth International Kidney Cancer International Symposium 2018 in Miami FL.

Exit mobile version